Pear Therapeutics reported new data that reinforce the effectiveness of Somryst, its prescription digital therapeutic for chronic insomnia in adults.
The app-based therapeutic includes self-paced lessons and activities that deliver cognitive behavioral therapy for insomnia and require 45 to 60 minutes per week, over the course of 6 to 9 weeks.
“Today, many people face barriers to accessing care, so the opportunity to provide patients with 24/7 virtual access to proven treatment options is more important than ever,” Yuri Maricich, MD, chief medical officer and head of development at